The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 64 | — | 20.1x | Near average | |
Growth | 62 | 5.4% | 5.6% | Near average | |
Quality | 43 | 22.4% | 7.6% | Near average | |
Safety | 47 | -0.4x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Surgery Partners, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Surgery Partners, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
SGRY stock saw stability in its average target price at $19.25 despite a new analyst recently joining the coverage, bringing the total number of analysts to three. This stability reflects a consensus on the stock's fair value, with a notable positive price gap between the current price ($13.4) and the lowest observed target price ($17), indicating cautious optimism despite the absence of changes in official valuations.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.